View in EDS HTML Full Text PDF Full Text

Chronic myelomonocytic leukemia treated with 5-azacytidine – results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system.

Saved in:
Bibliographic Details
Title: Chronic myelomonocytic leukemia treated with 5-azacytidine – results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system.
Authors: Diamantopoulos, Panagiotis T.1 (AUTHOR) pandiamantopoulos@gmail.com, Kotsianidis, Ioannis2 (AUTHOR), Symeonidis, Argiris3 (AUTHOR), Pappa, Vassiliki4 (AUTHOR), Galanopoulos, Athanasios5 (AUTHOR), Gogos, Dimitrios6 (AUTHOR), Karakatsanis, Stamatios7 (AUTHOR), Papadaki, Helen8 (AUTHOR), Palla, Aikaterini9 (AUTHOR), Hatzimichael, Eleftheria10 (AUTHOR), Dimou, Maria11 (AUTHOR), Papageorgiou, Sotirios4 (AUTHOR), Delimpasis, Sosana12 (AUTHOR), Papaioannou, Maria13 (AUTHOR), Papoutselis, Menelaos2 (AUTHOR), Kourakli, Alexandra3 (AUTHOR), Tsokanas, Dimitrios5 (AUTHOR), Anagnostopoulos, Achilles14 (AUTHOR), Kontos, Christos K.15 (AUTHOR), Panayiotidis, Panayiotis11 (AUTHOR)
Source: Leukemia & Lymphoma. Jul2019, Vol. 60 Issue 7, p1721-1730. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2018.1540783